Optimizing Tobacco Treatment Delivery for People Living With HIV
Medical University of South Carolina
231 participants
Dec 1, 2021
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate implementation outcomes to identify barriers and facilitators towards future implementation. Investigators hope to define best practices and optimize the delivery of smoking cessation interventions for people living with HIV.
Eligibility
Inclusion Criteria5
- Age 21 and older
- Current diagnosis of HIV
- Current smoker (defined as self-report of current smoking)
- Willing to be randomized
- English speaking
Exclusion Criteria4
- Currently taking part in any other tobacco treatment program or using cessation medication (i.e., taking nicotine replacement therapy or other cessation medications, enrolled in the Quitline, or in another study)
- Currently imprisoned
- Pregnant women
- Non-English speaking persons
Interventions
This is an opt-out, proactive approach to tobacco treatment by a clinical pharmacy specialist. The pharmacist will call patients and offer an individualized pharmacotherapy prescription. The patient must opt-out for it not to be sent to their pharmacy. The patient will also receive brief motivational interviewing and behavioral counseling from the pharmacist.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05019495